-
2014
Company Description
OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.
OccuRx, a Melbourne-based biopharmaceutical company, was established in 2014 with venture funding from the Medical Research Commercialisation Fund, Brandon Capital Partners and Uniseed. The Company’s primary focus is on the development of innovative therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis.
-
Manufacturer:
Science and Engineering -
Formed:
2014 -
Company Website:
-
Company E-mail:
-
Company Address:
Level 9, 278 Collins StreetMelbourneAustralia -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits